Ischemic bowel disease attributable to ergot
Related Experiment Video
Updated: Jan 14, 2026

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
Abstract:
A 50-year-old woman developed ischemic colitis temporally related to ingestion of a large dose of ergotamine tartrate. The patient did not have cardiovascular, metabolic, or inflammatory conditions predisposing to bowel ischemia. To our knowledge, this is the first patient proved to have developed bowel ischemia secondary to ergot toxicity.
Related Concept Videos
07:52In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
08:54In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression
11:53A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer
10:19Generation of Genetically Modified Mice through the Microinjection of Oocytes
13:10DNA Vector-based RNA Interference to Study Gene Function in Cancer
10:58Quantitative and Automated High-throughput Genome-wide RNAi Screens in C. elegans

